Stifel Financial’s Precision BioSciences DTIL Stock Holding History

Stifel Financial’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,270	Closed	-$191K	–	3408
2024 Q3	$191K	Sell	21,270 -9,185	-30%	-$88.4K	﹤0.01%	3152
2024 Q2	$296K	Sell	30,455 -9,416	-24%	-$111K	﹤0.01%	2923
2024 Q1	$541K	Sell	39,871 -11,657	-23%	-$143K	﹤0.01%	2563
2023 Q4	$564K	Buy	51,528 +733	+1%	+$7.9K	﹤0.01%	2498
2023 Q3	$520K	Sell	50,795 -14,501	-22%	-$223K	﹤0.01%	2467
2023 Q2	$1.03M	Buy	65,296 +34,993	+115%	+$800K	﹤0.01%	2069
2023 Q1	$685K	Sell	30,303 -1,144	-4%	-$37.7K	﹤0.01%	2324
2022 Q4	$1.12M	Buy	31,447 +8,246	+36%	+$326K	﹤0.01%	1906
2022 Q3	$905K	Sell	23,201 -955	-4%	-$45.4K	﹤0.01%	2040
2022 Q2	$1.16M	Buy	24,156 +20,209	+512%	+$1.19M	﹤0.01%	1891
2022 Q1	$365K	Buy	+3,947	New	+$536K	﹤0.01%	2752

Other funds holding DTIL

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

Stifel Financial's DTIL Position: Q4 2024 in Review

Stifel Financial sold out of Precision BioSciences (DTIL) in Q4 2024, closing a stake of 21,270 shares — an estimated $191K sold.

Stifel Financial first reported a position in DTIL in Q1 2022 and held it in 11 quarters. The position peaked at $1.16M in Q2 2022. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

Stifel Financial reported no remaining Precision BioSciences position as of Q4 2024 after selling out during the quarter.
Stifel Financial sold 21,270 Precision BioSciences shares in Q4 2024, an estimated $191K.
Stifel Financial first reported a position in Precision BioSciences in Q1 2022 and held it in 11 quarters.
Stifel Financial's Precision BioSciences position peaked at $1.16M in Q2 2022.
55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on Stifel Financial's 13F filing for Q4 2024, filed 13 Feb 2025.